FindTrial
Sign In

Can desmopressin reduce bleeding complication with impaired renal function

Study of The effect of Desmopressin in Reducing Post Kidney Biopsy Bleeding Complications in Patients with Reduced Renal Function - -

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048812
Enrollment
150
Registered
2023-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N059- Unspecified nephritic syndrome with unspecified morphologic changes

Interventions

Intervention1: DESMOPRESSIN: INTRANASAL DESMOPRESSIN (3MICROGM/KG) 1 HR BEFORE KIDNEY BIOPSY Control Intervention1: Normal saline: INTRANASAL NORMAL SALINE 1HR BEFORE KIDNEY BIOPSY

Sponsors

AIIMS JODHPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: eGFR LESS THAN OR EQUAL TO 60ML/MIN PLATELET COUNT >1LACK NORMAL COAGULATION PROFILE BP <140/90

Exclusion criteria

Exclusion criteria: SOLITARY KIDNEY RENAL CELL CARCINOMA HYDRO/PYONEPHROSIS CONTRATED KIDNEY BILATERAL MORBID OBESITY >40KG/M2 POST RENAL TRANSPLANT SEVERSE NASAL CONGESTION,BLOCKAGE,ATROPHIC RHINITIS SERUM SODIUM <125mEq/L

Design outcomes

Primary

MeasureTime frame
INCIDENCE OF POST KIDNEY BIOPSY BLEEDING COMPLICATION (perirenal hematoma, gross hematuria, AV fistula formation, Blood transfusion, arterial embolization or death)Timepoint: at 6 hrs and 24 hrs post biopsy—

Secondary

MeasureTime frame
PREDICTOR OF BLEEDING COMPLICATIONTimepoint: AT 24 HR POST PROCEDURE—

Countries

India

Contacts

Public ContactUttayan Chakrabarti

Nephrology Department, AIIMS Jodhpur

jhorawat2000@gmail.com9461626614

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026